Fig. 2: Overall survival by bone marrow status.

Kaplan–Meier plots show overall survival by baseline bone marrow blasts (<50%, 50–90%, and >90%) for patients in the (a) InO arm and (b) SC arm. BMB bone marrow blasts, InO inotuzumab ozogamicin, OS overall survival, SC standard of care chemotherapy.